Venn Life Sciences Holdings (VENN)

 

VENN Share PerformanceMore

52 week high28.740 26/09/16
52 week low12.030 18/09/17
52 week change -15.625 (-55.31%)
4 week volume1,879,049 24/08/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Grant of Stock Options

RNS Number: 8182Q Venn Life Sciences Holdings PLC 14 September 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company" or the "Group") Grant of Stock Options to Directors and Management Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to...

Venn Life Sciences swings to operating profit

Venn Life Sciences swung to an operating profit of 0.01m, up from a loss of 0.03m in the first half of 2017. FINANCIAL H...

Half-year Report

RNS Number: 4324Q Venn Life Sciences Holdings PLC 12 September 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company" or the "Group") Half-year Report Interim Results for 6 months ended 30 June 2017 Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and re...

Senior Management Appointment

RNS Number: 9357L Venn Life Sciences Holdings PLC 25 July 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company" or the "Group") Senior Management Appointment Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechn...

Venn Life Sciences reports strong start to 2017

Venn Life Sciences announced the new financial year started well with contract wins of 5.7m secured in January and Feb...

Half year end update

RNS Number: 5675L Venn Life Sciences Holdings PLC 20 July 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company" or the "Group") Half year end update Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and m...

Result of AGM

RNS Number: 4690D Venn Life Sciences Holdings PLC 26 April 2017 26 April 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company") Result of Annual General Meeting Venn Life Sciences Holdings plc (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to phar...

Proposed amendment to AGM resolution

RNS Number: 3003D Venn Life Sciences Holdings PLC 25 April 2017 25 April 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company") AGM update Proposed amendment to resolution to be considered at AGM Venn Life Sciences Holdings plc (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial manag...

Equity Research (VENN)

Venn Life Sciences Holdings plc
12/09/2017
The developer of advanced security and surveillance systems has reported an excellent set of HY June 2017 results. Revenue grew 8% to £8m with EBITDA up 18% to £925k driven by gross margin...
Venn Life Sciences Holdings plc
12/09/2017
The growing Contract Research Organisation has published H1 June 2017 results. Despite the deferral of a late phase project into Q1 2018 VENN still managed to deliver 1% revenue growth to €9.15m and...
Venn Life Sciences Holdings plc
09/08/2017
Last week saw the acquisition of Aptuit by Evotec (EVT.DE) for $300m. This is against forecasted revenues 2017 of €100m to €110m a multiple of circa 2.4x (forward) and adjusted EBITDA in 2016 of €...

Latest discussion posts More

  • New research from Davy

    Davy Stockbrokers have produced a new note on VENN - client-only, but the intro sounds positive ...
    15-Sep-2017
    gretel
  • RNS : shareholder-friendly options

    I for one will be extremely happy for the directors if the share price exceeds the 45p required for full vesting of the options issued to them yesterday: "The options vest ...
    15-Sep-2017
    gretel
  • Bargain time imho

    My prior post stated I didn't think VENN would achieve Hybridan's forecasts this year - I reckoned on a ?600k PBT rather than Hybridan's ?1.27m PBT. Well whaddyaknow - ...
    13-Sep-2017
    gretel

Users' HoldingsMore

Users who hold Venn Life Sciences Holdings also hold..
AMINO TECH21%
APC TECHNOLOGY21%
BT GROUP10%
NCC GRP10%
ROCKHOPPER10%

Codes & Symbols

ISINGB00B9275X97
SymbolsVENN, LSE:VENN, VENN.L, VENN:LN, LON:VENN, XLON:VENN